Testing for epidermal growth factor (EFGR) mutation in non-small cell lung cancer (NSCLC) patients; the Heart of England NHS Foundation Trust (HEFT) experience

被引：0
|
作者：
Kussaibati, R. [1 ]
Mansukhani, S. [1 ]
Chan, L. [1 ]
Herring, K. [1 ]
Baijal, S. [1 ]
机构：
[1] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70021-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Epidermal Growth Factor Receptor (EGFR) Mutation Testing in non-small cell lung cancer (NSCLC) patients
    Wallace, Andrew
    Howard, E.
    Dutton, L.
    Elles, R. G.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2010, 47 : S66 - S66
  • [2] Epidermal Growth Factor Receptor (EGFR) mutation testing in non-small cell lung cancer (NSCLC) patients
    Eaton, Helen
    Dutton, L.
    Wallace, A. J.
    Howard, E.
    Gaunt, L.
    Blackhall, F.
    Newman, W.
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 : S72 - S72
  • [3] Testing for programmed death receptor ligand (PD-L1) in metastatic non-small-cell lung cancer (NSCLC) patients; the Heart of England NHS Foundation Trust (HEFT) experience
    Bancroft, H.
    Kussaibati, R.
    Hanna, T.
    Langman, G.
    Baijal, S.
    [J]. LUNG CANCER, 2017, 103 : S37 - S38
  • [4] Epidermal growth factor mutation in non-small cell lung cancer: Venezuelan experience.
    Oblitas Alca, George
    Belen Fuentes, Maria
    Jose Rodriguez, Juan Jose
    Garcia, Cristina
    Angelina Perez, Maria
    Kubicek, Karen
    Nunez, Patricia
    Pichelbauer, Ernestina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [6] Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience
    Khalique, Saira
    Lubel, Jessica
    Docherty, Catherine
    Kanu, Abimbola
    Etessami, Nazanin
    MacMahon, Suzanne
    Peters, Natalie
    Pender, Alexandra
    Patel, Anant
    Boleti, Ekaterini
    [J]. LUNG CANCER, 2021, 156 : S38 - S38
  • [7] Using programmed death-1 (PD-1) inhibitors in the treatment of metastatic non-small cell lung cancers (NSCLC) at Heart of England NHS Foundation Trust (HEFT)
    Powell, R. L.
    Kussaibati, R.
    Baijal, S.
    [J]. LUNG CANCER, 2018, 115 : S34 - S35
  • [8] Prevalence of epidermal growth factor receptor (EGFR) mutation in an Ecuadorian population with non-small cell lung cancer (NSCLC).
    Rivas, Carmen
    Martinez, Luis A.
    Eduardo Teran, Enrique
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) IN AN IRISH POPULATION
    Graham, Donna M.
    O'Connor, Kate
    Teo, Min Y.
    Burke, Louise
    Mccarthy, Julie
    O'Dea, Pauline
    O'Keefe, Margaret
    Moylan, Eugene J.
    Power, Derek G.
    O'Reilly, Seamus
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1527 - S1528
  • [10] Epidermal growth factor receptor mutation (EGFRMUT) in non-small cell lung cancer (NSCLC) in the Middle East.
    Jazieh, Abdul Rahman
    Jaafar, Hassan Nadim
    Mustafa, Rasha
    Rasul, Kakil
    Zekri, Jamal
    Gaafar, Rabab Mohamed
    Al Husaini, Hamed Homoud
    Azim, Hamdy A.
    Bamefleh, Hanaa
    Gasmelseed, Ahmed
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345